Incorporating scores from two urine-based biomarker assays may reduce the number of biopsies men with clinically localized prostate cancer need to undergo without greatly affecting 10-year survival rates, according to the results of a decision analysis. Read the article.
Urine biomarkers may reduce repeat biopsies for prostate cancer Read More »
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have shown that the cells responsible for generating deadly prostate cancer share some genetic qualities with the tissue-specific stem cells that naturally reside in the healthy prostate. Read the article.
UCLA-led study shows deadly prostate cancer cells have stem cell qualities Read More »
A revolutionary prostate biopsy approach uses fewer needles and is more accurate for diagnosing prostate cancer. It is done during a real time MRI (magnetic resonance imaging) scan that clearly shows suspicious sites. When done by an expert radiologist using a highly powerful magnet, only a minimum number of needles are used to sample suspicious abnormalities. Read the article.
Revolutionary prostate biopsy approach more accurate at diagnosing prostate cancer Read More »
The study provides compelling evidence that few benign cancer suspicious regions increase in suspicion score and/or the greatest linear measurement within 1 year independent of the baseline suspicion score. Therefore, routinely repeating multiparametric magnetic resonance imaging at 1 year in men with pathologically benign cancer suspicious regions should be discouraged since it is unlikely to influence management decisions. Read the article.
A cheap test which can gauge the size of prostate cancer tumours has the potential to save thousands of lives each year, scientists believe The new test, which works like a pregnancy test, is twice as reliable as the current PSA blood test and would allow patients to find out in minutes whether they had cancer based on the levels of EN2 in their urine – a protein which is produced by tumours. Read the article.
Prostate cancer test that detects tumour size could save thousands of lives Read More »
Listen to and read about an interview with Dr. Levin in which he goes into greater depth on how to discuss prognosis with cancer patients. Read the article.
Discussing Cancer Prognosis Read More »
The year 2014 has again provided important developments in the area of prostate cancer. New data and new treatments span the spectrum of prostate cancer management, from prevention and screening to optimal strategies for localized, locally advanced, and metastatic disease. Read the article. (Free Medscape account required.)
Advances in Prostate Cancer: 2014 Read More »
(TORONTO, Canada – Nov. 13, 2014) – Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy. Read the article.
Prostate cancer researchers develop personalized genetic test to predict recurrence risk Read More »
In recent years, various task forces or panels have come out strongly against using the PSA blood test as a screening tool. The latest was the Canadian Task Force on Preventive Health Care (CTFPHC) which, on Monday October 27th, 2014 stated that this test should not be used, as it does not prove to save lives!
Our Position on PSA Screening Read More »
Many men may not be getting the best advice when it comes to managing low-risk prostate cancer, two new studies suggest. In the first study, researchers found that most men are getting their prostate removed or undergoing radiation therapy when carefully watching the cancer may be just as effective without the risks and side effects of surgery or radiation. Read the article.
Doctors suggest widely varying treatments; second opinion vital Read More »